Viewing Study NCT00867932


Ignite Creation Date: 2025-12-24 @ 9:33 PM
Ignite Modification Date: 2025-12-31 @ 12:15 AM
Study NCT ID: NCT00867932
Status: COMPLETED
Last Update Posted: 2018-10-31
First Post: 2009-03-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Eculizumab Pharmacokinetics/Pharmacodynamics Study in Pediatric/Adolescent Paroxysmal Nocturnal Hemoglobinuria (PNH)
Sponsor: Alexion Pharmaceuticals, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-10-02
Start Date Type: ACTUAL
Primary Completion Date: 2011-05-12
Primary Completion Date Type: ACTUAL
Completion Date: 2011-05-12
Completion Date Type: ACTUAL
First Submit Date: 2009-03-23
First Submit QC Date: None
Study First Post Date: 2009-03-24
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2018-10-03
Results First Submit QC Date: None
Results First Post Date: 2018-10-31
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2017-03-10
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2018-10-03
Last Update Post Date: 2018-10-31
Last Update Post Date Type: ACTUAL